Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) E10: ¥0.42 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603707 Nanjing King-Friend Biochemical Pharmaceutical Co Ltd SHSE:603707
65 GF Score
Price ¥7.55
GF Value ¥12.70
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Nanjing King-Friend Biochemical Pharmaceutical Co E10?

Nanjing King-Friend Biochemical Pharmaceutical Co SHSE:603707 -4.07% 65 E10 is ¥0.42 as of Mar. 2026. GuruFocus rates SHSE:603707 with a GF Score™ of 65/100 and a GF Value™ of ¥12.70 (Significantly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Nanjing King-Friend Biochemical Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.42 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Nanjing King-Friend Biochemical Pharmaceutical Co's average E10 Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-26), Nanjing King-Friend Biochemical Pharmaceutical Co's current stock price is ¥7.55. Nanjing King-Friend Biochemical Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ¥0.42. Nanjing King-Friend Biochemical Pharmaceutical Co's Shiller PE Ratio of today is 17.98.

During the past 13 years, the highest Shiller PE Ratio of Nanjing King-Friend Biochemical Pharmaceutical Co was 33.41. The lowest was 16.29. And the median was 24.00.


Nanjing King-Friend Biochemical Pharmaceutical Co  (SHSE:603707) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Nanjing King-Friend Biochemical Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=7.55/0.42
=17.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Nanjing King-Friend Biochemical Pharmaceutical Co was 33.41. The lowest was 16.29. And the median was 24.00.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Nanjing King-Friend Biochemical Pharmaceutical Co E10 Related Terms


Nanjing King-Friend Biochemical Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Nanjing King-Friend Biochemical Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanjing King-Friend Biochemical Pharmaceutical Co E10 Chart

Nanjing King-Friend Biochemical Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.41

Nanjing King-Friend Biochemical Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.41 0.41 0.41 0.42

SHSE:603707 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nanjing King-Friend Biochemical Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanjing King-Friend Biochemical Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanjing King-Friend Biochemical Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nanjing King-Friend Biochemical Pharmaceutical Co's Shiller PE Ratio falls into.


SHSE:603707
65GF Score
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd SHSE:603707
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanjing King-Friend Biochemical Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nanjing King-Friend Biochemical Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.05/116.3033*116.3033
=0.050

Current CPI (Mar. 2026) = 116.3033.

Nanjing King-Friend Biochemical Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.118 101.400 0.135
201609 0.013 102.400 0.015
201612 0.039 102.600 0.044
201703 0.032 103.200 0.036
201706 0.050 103.100 0.056
201709 0.069 104.100 0.077
201712 0.053 104.500 0.059
201803 0.077 105.300 0.085
201806 0.067 104.900 0.074
201809 0.068 106.600 0.074
201812 0.073 106.500 0.080
201903 0.124 107.700 0.134
201906 0.112 107.700 0.121
201909 0.101 109.800 0.107
201912 0.131 111.200 0.137
202003 0.169 112.300 0.175
202006 0.169 110.400 0.178
202009 0.130 111.700 0.135
202012 0.150 111.500 0.156
202103 0.220 112.662 0.227
202106 0.240 111.769 0.250
202109 0.183 112.215 0.190
202112 0.140 113.108 0.144
202203 0.210 114.335 0.214
202206 0.170 114.558 0.173
202209 0.180 115.339 0.182
202212 0.110 115.116 0.111
202303 0.200 115.116 0.202
202306 0.180 114.558 0.183
202309 0.130 115.339 0.131
202312 -0.640 114.781 -0.648
202403 0.110 115.227 0.111
202406 0.140 114.781 0.142
202409 0.120 115.785 0.121
202412 0.130 114.893 0.132
202503 0.050 115.116 0.051
202506 0.130 114.907 0.132
202509 0.090 115.471 0.091
202512 0.090 115.832 0.090
202603 0.050 116.303 0.050

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.42 mean?
Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) has a E10 of ¥0.42 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Nanjing King-Friend Biochemical Pharmaceutical Co and its competitors.
Is Nanjing King-Friend Biochemical Pharmaceutical Co's E10 too high?
Nanjing King-Friend Biochemical Pharmaceutical Co's current E10 is ¥0.42. Overall, Nanjing King-Friend Biochemical Pharmaceutical Co has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nanjing King-Friend Biochemical Pharmaceutical Co's E10 compare to ZTS and UTHR?
Nanjing King-Friend Biochemical Pharmaceutical Co's E10 of ¥0.42 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Nanjing King-Friend Biochemical Pharmaceutical Co and its competitors. Nanjing King-Friend Biochemical Pharmaceutical Co's current E10 is ¥0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing King-Friend Biochemical Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥12.70, compared to a current price of ¥7.55 — trading 40.6% below its estimated fair value. The current E10 is ¥0.42. Nanjing King-Friend Biochemical Pharmaceutical Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707), the current E10 is ¥0.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Overvalued in 2026?

Based on GuruFocus' analysis, Nanjing King-Friend Biochemical Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥7.55 is trading 40.6% below its estimated GF Value™ of ¥12.70. GuruFocus considers Nanjing King-Friend Biochemical Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:603707:

  • E10: ¥0.42
  • GF Value™: ¥12.70 vs. price of ¥7.55 (40.6% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nanjing King-Friend Biochemical Pharmaceutical Co Business Description

Address 1/16 Xuefu Road, Nanjing High-Tech Zone, Nanjing, CHN, 210061
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is a China-based company engaged in the research and development, import and export of medicines and health products. The main products of the company are Heparin sodium and low molecular weight heparin. Geographically, the business activities are carried out through China and it exports the product mainly to the European and American countries.
65GF Score

Get the complete analysis for SHSE:603707

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.55
Price
¥12.70
GF Value